top of page

Our Story

LabShares was born of a small biotech success story. CEO and Founder Jeff Behrens, a serial entrepreneur in the life science space, began his search for lab space in Newton in 2014 while serving as CEO for Siamab Therapeutics. Tired of the long commute to Cambridge, he led Siamab build a lab in ChapelBridge Park in the Nonantum section of Newton, a community of historical mill buildings repurposed for today's needs. Siamab thrived at ChapelBridge park through its successful exit in 2019.

With Siamab's exit leaving the lab space unoccupied, Jeff began work to re-fit the space as an incubator. This idea was fueled by his own experiences at Siamab; he wanted small, "scrappy" startups to have access to amenities offered by top-tier labs in Kendall Square without the drawbacks of commute fatigue, parking costs, and high real estate prices. Thus, LabShares was born with the mission to provide top-quality service to a diverse group of life science startups.

Since the initial opening of LabShares in 2018, the company has expanded several times and now occupies more than triple our initial footprint. We now offer a wide range of utilities and resources to companies seeking as little as one bench all the way up to large private suites. Though we continue to grow, our purpose remains the same; to deliver fully equipped, outfitted, and permitted lab space, staffed by industry-savvy professionals ready to help members find the answer to any question while they focus on discovering the cures of tomorrow.


Our Team

David Baxley,
Site Director

David is the Site Director at LabShares, 55 Chapel St. He previously managed the facilities at M2D2 in Lowell, MA and brings 25 years of Navy experience to the table.

  • White LinkedIn Icon
Jeff Behrens, PhD
CEO, Founder

Jeff is the CEO and founder of LabShares. Jeff is a serial entrepreneur who has run multiple biotechs himself in the past, and currently serves as an advisor to many others.

Hannah leads business development and client relations for LabShares. She has a BS in molecular biology, and focuses both on external events and marketing, as well as serving as LabShares biosafety officer.

  • White LinkedIn Icon
Hannah Schram,
Manager of Corporate Development
Barry Braunstein Photography Headshots Boston - Jackie Ellis 01621 2.jpg
Jackie Ellis,
Manager of Finance and Operations

Jackie heads up the financial management of LabShares. She serves as a site admin for one of our labs and manages customer accounts as well as billing, purchasing, and more.

Barry Braunstein Photography Headshots Boston - Barry Lawton 01551 4.jpg
Barry Lawton,
Site Director
  • White LinkedIn Icon

Barry is a long time IT professional who has served multiple companies over the past 30 years. He leads our in house technology management, and is the site director for 90 Bridge St.

Barry Braunstein Photography Headshots Boston - Labshares - Emma Orfanos 01479_edited.jpg

Emma is a recent graduate of the College of Natural Sciences, University of Massachusetts, with a BS in Psychology with a concentration in Neuroscience. She aids in onboarding, member relations and laboratory management. 

  • White LinkedIn Icon
Emma Orfanos,
Lab Associate
Advisory Board

Advisory Board
LinkedIn info for advisory board members available when hovering with cursor!


LabShares Sponsors





DT Ward, PC is a boutique intellectual property law firm devoted exclusively to the practice of patent law in the startup biotechnology, medical device, and pharmaceutical industries. The firm’s unique On-Site Counsel business model helps clients create, transform and leverage sustainable portfolios through comprehensive integration of its patent practitioners with the client’s internal science and business teams. The firm’s attorneys, patent agents and technical specialist all hold advanced degrees in science or engineering and have experience in industry and academia. Founded in 2010, the firm is located in beautiful Groton, Massachusetts.




Faber Daeufer & Itrato is a dynamic, independent law firm that provides corporate and transactional counsel to clients in the drug and life sciences industries, and in other emerging technology sectors including cleantech and cloud computing. Since its founding in 2003, the firm has built a premier boutique practice working with over 1,000 companies, research institutions and investors in the life sciences and other emerging technology sectors. The firm includes over 30 lawyers, contracts specialists, and paralegals, whose collective experience handling life science and emerging technologies business transactions and in-house operational knowledge are extraordinary in a law firm. The firm is based in Waltham, Massachusetts and has offices in New York, Philadelphia and San Francisco.​​

Safety Partners creates and implements high quality, customized EHS programs for life science companies.  For 25 years over 500 companies have turned to Safety Partners to provide best-in-class environmental, health, and safety (EHS) programs. They pride themselves on strong, long-standing client relationships and their ability to tailor services to meet comprehensive EHS requirements.

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 100,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

Tobin Scientific works closely with principal investigators, environmental health and safety officers, lab managers, and operations teams to develop and enhance projects ranging from full laboratory relocations, frozen biological transport, biorepository services, contingency plans, risk management and emergency response.

Screenshot 2019-03-07 08.56.57.png
Screenshot 2019-03-07 09.02.11.png
Screenshot 2019-03-07 09.05.07.png
Thermo Fisher Scientific - Tagline.jpg
bottom of page